IMRAN KASSIM: Open Payments
NPI 1801435078 · JAMAICA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$507 in 23 payments from 8 companies in 2025. Trend: 2023 $1,023 · 2024 $309 · 2025 $507
Food & beverage: $507
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 11 | $229 |
| Janssen Biotech, Inc. | 5 | $91 |
| Regeneron Healthcare Solutions, Inc. | 2 | $72 |
| PFIZER INC. | 1 | $29 |
| ABBVIE INC. | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| LEO Pharma Inc. | 1 | $20 |
| UCB, Inc. | 1 | $15 |
Products named: OPZELURA, TREMFYA, DUPIXENT, CIBINQO, SKYRIZI, SPEVIGO, ANZUPGO, Bimzelx.
Industry payments across NY — which companies pay providers there.
